Skip to main content

Paul

Analyst

J.P. Morgan

Equibles does not estimate personal net worth.

About Paul

Paul is recorded as Analyst at J.P. Morgan. Paul has spoken on 2 earnings calls across 2 companies, most recently for Guardant Health, Inc. on November 5, 2026. Those appearances were for Guardant Health, Inc. (GH) and Revvity, Inc. (RVTY). The companies whose calls Paul spoke on are classified in the Healthcare sector.

Paul on recent calls

“Just wondering if you could share anything about the benefit you might see from the U.S. midterm election result in terms of ACA headwind dissipating, potentially, you know, broadly increased healthcare utilization or any other catalyst that might come out of that result.”
Analyst — JP Morgan, Guardant Health Q3 2026 Earnings Call ·
“So it looks like your 4Q guide, aside from pulling out the 100 BIPs that you talked about for the screening reagents bulk orders, is essentially the same on the top and bottom lines.”
Analyst — J.P. Morgan, Q3 2026 Revvity Earnings Conference Call ·

Affiliation history

  • J.P. Morgan

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity